Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Margin

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 13.2713.0111.588.9713.44

What is the latest Core EBITDA Margin ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Margin ratio of ALKEM LABORATORIES is 13.27 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202613.27
Mar202513.01
Mar202411.58
Mar20238.97
Mar202213.44

How is Core EBITDA Margin of ALKEM LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2026 13.27
2.00
Mar2025 13.01
12.35
Mar2024 11.58
29.10
Mar2023 8.97
-33.26
Mar2022 13.44 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Margin ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹63,987.8 Cr -0.1% -8% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

-0.1%

-8%

-2.1%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses